<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34638733</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>19</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Targeting the RNA-Binding Protein HuR as Potential Thera-Peutic Approach for Neurological Disorders: Focus on Amyo-Trophic Lateral Sclerosis (ALS), Spinal Muscle Atrophy (SMA) and Multiple Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10394</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms221910394</ELocationID><Abstract><AbstractText>The importance of precise co- and post-transcriptional processing of RNA in the regulation of gene expression has become increasingly clear. RNA-binding proteins (RBPs) are a class of proteins that bind single- or double-chain RNA, with different affinities and selectivity, thus regulating the various functions of RNA and the fate of the cells themselves. ELAV (embryonic lethal/abnormal visual system)/Hu proteins represent an important family of RBPs and play a key role in the fate of newly transcribed mRNA. ELAV proteins bind AU-rich element (ARE)-containing transcripts, which are usually present on the mRNA of proteins such as cytokines, growth factors, and other proteins involved in neuronal differentiation and maintenance. In this review, we focused on a member of ELAV/Hu proteins, HuR, and its role in the development of neurodegenerative disorders, with a particular focus on demyelinating diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borgonetti</LastName><ForeName>Vittoria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-2203-5285</Identifier><AffiliationInfo><Affiliation>Department NEUROFARBA, Division of Pharmacology and Toxicology, University of Florence, 50139 Firenze, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppi</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4434-5919</Identifier><AffiliationInfo><Affiliation>Department NEUROFARBA, Division of Pharmacology and Toxicology, University of Florence, 50139 Firenze, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galeotti</LastName><ForeName>Nicoletta</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-1812-9844</Identifier><AffiliationInfo><Affiliation>Department NEUROFARBA, Division of Pharmacology and Toxicology, University of Florence, 50139 Firenze, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019/R-Single/036 (EC)</GrantID><Agency>Fondazione Italiana Sclerosi Multipla</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067780">ELAV-Like Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C098770">ELAVL1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067780" MajorTopicYN="Y">ELAV-Like Protein 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="Y">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="Y">Muscular Atrophy, Spinal</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ELAV/Hu</Keyword><Keyword MajorTopicYN="N">HuR</Keyword><Keyword MajorTopicYN="N">RNA-binding proteins (RPBs)</Keyword><Keyword MajorTopicYN="N">demyelination</Keyword><Keyword MajorTopicYN="N">glia</Keyword><Keyword MajorTopicYN="N">neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">neuroprotection</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34638733</ArticleId><ArticleId IdType="pmc">PMC8508990</ArticleId><ArticleId IdType="doi">10.3390/ijms221910394</ArticleId><ArticleId IdType="pii">ijms221910394</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schuschel K., Helwig M., H&#xfc;ttelmaier S., Heckl D., Klusmann J.-H., Hoell J.I. RNA-binding proteins in acute leukemias. Int. J. Mol. Sci. 2020;21:3409. doi: 10.3390/ijms21103409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103409</ArticleId><ArticleId IdType="pmc">PMC7279408</ArticleId><ArticleId IdType="pubmed">32408494</ArticleId></ArticleIdList></Reference><Reference><Citation>Hentze M., Castello A., Schwarzl T., Preiss T. A brave new world of RNA-binding proteins. Nat. Rev. Mol. Cell Biol. 2018;19:327&#x2013;341. doi: 10.1038/nrm.2017.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.130</ArticleId><ArticleId IdType="pubmed">29339797</ArticleId></ArticleIdList></Reference><Reference><Citation>Glisovic T., Bachorik J.L., Yong J., Dreyfuss G. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 2008;582:1977&#x2013;1986. doi: 10.1016/j.febslet.2008.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.03.004</ArticleId><ArticleId IdType="pmc">PMC2858862</ArticleId><ArticleId IdType="pubmed">18342629</ArticleId></ArticleIdList></Reference><Reference><Citation>Maris C., Dominguez C., Allain F.H.-T. The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression. FEBS J. 2005;272:2118&#x2013;2131. doi: 10.1111/j.1742-4658.2005.04653.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2005.04653.x</ArticleId><ArticleId IdType="pubmed">15853797</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerstberger S., Hafner M., Tuschl T. A census of human RNA-binding proteins. Nat. Rev. Genet. 2014;15:829&#x2013;845. doi: 10.1038/nrg3813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3813</ArticleId><ArticleId IdType="pubmed">25365966</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Mu&#xf1;oz M.D., Turner M. Uncovering the role of RNA-binding proteins in gene expression in the immune system. Front. Immunol. 2018;9:1094. doi: 10.3389/fimmu.2018.01094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01094</ArticleId><ArticleId IdType="pmc">PMC5974052</ArticleId><ArticleId IdType="pubmed">29875770</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami N., Smith R.B., Carrasco M.A., Williams L.A., Winborn C.S., Han S.S., Kiskinis E., Winborn B., Freibaum B.D., Kanagaraj A., et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81:536&#x2013;543. doi: 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell R.B. RNA protein interaction in neurons. Annu. Rev. Neurosci. 2013;36:243&#x2013;270. doi: 10.1146/annurev-neuro-062912-114322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-062912-114322</ArticleId><ArticleId IdType="pmc">PMC3889695</ArticleId><ArticleId IdType="pubmed">23701460</ArticleId></ArticleIdList></Reference><Reference><Citation>Re A., Joshi T., Kulberkyte E., Morris Q., Workman C.T. Chapter 23 RNA&#x2013;Protein Interactions: An Overview. Volume 1097. Springer; Berlin/Heidelberg, Germany: 2014.</Citation></Reference><Reference><Citation>Cookson M.R. RNA-binding proteins implicated in neurodegenerative diseases. Wiley Interdiscip. Rev. RNA. 2016;8:e1397. doi: 10.1002/wrna.1397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1397</ArticleId><ArticleId IdType="pmc">PMC5179305</ArticleId><ArticleId IdType="pubmed">27659605</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bruin R.G., Rabelink T., van Zonneveld A.J., Van Der Veer E.P. Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease. Eur. Heart J. 2016;38:1380&#x2013;1388. doi: 10.1093/eurheartj/ehw567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw567</ArticleId><ArticleId IdType="pubmed">28064149</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurth L. Versatility of RNA-binding proteins in cancer. Comp. Funct. Genom. 2012;2012:1&#x2013;11. doi: 10.1155/2012/178525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/178525</ArticleId><ArticleId IdType="pmc">PMC3359819</ArticleId><ArticleId IdType="pubmed">22666083</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman R., McHugh J., Turner M. RNA binding proteins as regulators of immune cell biology. Clin. Exp. Immunol. 2015;183:37&#x2013;49. doi: 10.1111/cei.12684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12684</ArticleId><ArticleId IdType="pmc">PMC4687516</ArticleId><ArticleId IdType="pubmed">26201441</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussbacher J., Batra R., Lagier-Tourenne C., Yeo G.W. RNA-binding proteins in neurodegeneration: Seq and you shall receive. Trends Neurosci. 2015;38:226&#x2013;236. doi: 10.1016/j.tins.2015.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2015.02.003</ArticleId><ArticleId IdType="pmc">PMC4403644</ArticleId><ArticleId IdType="pubmed">25765321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinoshita C., Kubota N., Aoyama K. Interplay of RNA-binding proteins and microRNAs in neurodegenerative diseases. Int. J. Mol. Sci. 2021;22:5292. doi: 10.3390/ijms22105292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22105292</ArticleId><ArticleId IdType="pmc">PMC8157344</ArticleId><ArticleId IdType="pubmed">34069857</ArticleId></ArticleIdList></Reference><Reference><Citation>Gantois I., Khoutorsky A., Popic J., Aguilar-Valles A., Freemantle E., Cao R., Sharma V., Pooters T., Nagpal A., Skalecka A., et al. Metformin ameliorates core deficits in a mouse model of fragile X syndrome. Nat. Med. 2017;23:674&#x2013;677. doi: 10.1038/nm.4335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4335</ArticleId><ArticleId IdType="pubmed">28504725</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumina V., Colombrita C., Fallini C., Bossolasco P., Maraschi A.M., Landers J.E., Silani V., Ratti A. TDP-43 and NOVA-1 RNA-binding proteins as competitive splicing regulators of the schizophrenia-associated TNIK gene. Biochim. Biophys. Acta (BBA) Bioenerg. 2019;1862:194413. doi: 10.1016/j.bbagrm.2019.194413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2019.194413</ArticleId><ArticleId IdType="pmc">PMC7818381</ArticleId><ArticleId IdType="pubmed">31382054</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlanis E., Scheiffele P. Europe PMC funders group regulation of neuronal differentiation, function, and plasticity by alternative splicing. Ann. Rev. Cell Dev. Biol. 2018;34:451&#x2013;469. doi: 10.1146/annurev-cellbio-100617-062826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100617-062826</ArticleId><ArticleId IdType="pmc">PMC6697533</ArticleId><ArticleId IdType="pubmed">30028642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirisis A., Carew T.J. The ELAV family of RNA-binding proteins in synaptic plasticity and long-term memory. Neurobiol. Learn. Mem. 2019;161:143&#x2013;148. doi: 10.1016/j.nlm.2019.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nlm.2019.04.007</ArticleId><ArticleId IdType="pmc">PMC6529270</ArticleId><ArticleId IdType="pubmed">30998973</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn G.I., Okano H.J., Jensen K., Park W.-Y., Zhong R., Ule J., Mele A., Fak J.J., Yang C., Zhang C., et al. Neuronal elav-like (HU) Proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron. 2012;75:1067&#x2013;1080. doi: 10.1016/j.neuron.2012.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.07.009</ArticleId><ArticleId IdType="pmc">PMC3517991</ArticleId><ArticleId IdType="pubmed">22998874</ArticleId></ArticleIdList></Reference><Reference><Citation>Twyffels L., Gueydan C., Kruys V. Transportin-1 and Transportin-2: Protein nuclear import and beyond. FEBS Lett. 2014;588:1857&#x2013;1868. doi: 10.1016/j.febslet.2014.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.04.023</ArticleId><ArticleId IdType="pubmed">24780099</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikantan S., Gorospe M. HuR function in disease. Front. Biosci. 2012;17:189&#x2013;205. doi: 10.2741/3921.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/3921</ArticleId><ArticleId IdType="pmc">PMC4540328</ArticleId><ArticleId IdType="pubmed">22201738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakheet T., Williams B., Khabar K.S.A. ARED 3.0: The large and diverse AU-rich transcriptome. Nucleic Acids Res. 2006;34:D111&#x2013;D114. doi: 10.1093/nar/gkj052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkj052</ArticleId><ArticleId IdType="pmc">PMC1347415</ArticleId><ArticleId IdType="pubmed">16381826</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognani F., Perrone-Bizzozero N.I. RNA&#x2013;protein interactions and control of mRNA stability in neurons. J. Neurosci. Res. 2008;86:481&#x2013;489. doi: 10.1002/jnr.21473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21473</ArticleId><ArticleId IdType="pubmed">17853436</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanger S.A., Bassell G.J. Making and breaking synapses through local mRNA regulation. Curr. Opin. Genet. Dev. 2011;21:414&#x2013;421. doi: 10.1016/j.gde.2011.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2011.04.002</ArticleId><ArticleId IdType="pmc">PMC3149745</ArticleId><ArticleId IdType="pubmed">21530231</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone-Bizzozero N., Bird C.W. Role of HuD in nervous system function and pathology. Front. Biosci. (Schol. Ed.) 2013;5:554&#x2013;563. doi: 10.2741/S389.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/S389</ArticleId><ArticleId IdType="pubmed">23277068</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaxall B.C., Dwyer-Nield L.D., Bauer A.K., Bohlmeyer T.J., Malkinson A.M., Port J.D. Differential expression and local-ization of the MRNA binding proteins, AU-rich element MRNA binding protein (AUF1) and Hu antigen R (HuR), in neo-plastic lung tissue. Mol. Carcinog. 2000;28:76&#x2013;83. doi: 10.1002/1098-2744(200006)28:2&lt;76::AID-MC3&gt;3.0.CO;2-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1098-2744(200006)28:2&lt;76::AID-MC3&gt;3.0.CO;2-0</ArticleId><ArticleId IdType="pubmed">10900464</ArticleId></ArticleIdList></Reference><Reference><Citation>Denkert C., Weichert W., Winzer K.-J., M&#xfc;ller B.-M., Noske A., Niesporek S., Kristiansen G., Guski H., Dietel M., Hauptmann S. Expression of the ELAV-like protein hur is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin. Cancer Res. 2004;10:5580&#x2013;5586. doi: 10.1158/1078-0432.CCR-04-0070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-04-0070</ArticleId><ArticleId IdType="pubmed">15328200</ArticleId></ArticleIdList></Reference><Reference><Citation>De Silanes I.L., Fan J., Yang X., Zonderman A.B., Potapova O., Pizer E.S., Gorospe M. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene. 2003;22:7146&#x2013;7154. doi: 10.1038/sj.onc.1206862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1206862</ArticleId><ArticleId IdType="pubmed">14562043</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippova N., Yang X., Wang Y., Gillespie G.Y., Langford C., King P., Wheeler C., Nabors L.B. The RNA-binding protein HuR promotes glioma growth and treatment resistance. Mol. Cancer Res. 2011;9:648&#x2013;659. doi: 10.1158/1541-7786.MCR-10-0325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-10-0325</ArticleId><ArticleId IdType="pmc">PMC3096748</ArticleId><ArticleId IdType="pubmed">21498545</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal A., Kawai T., Yang X., Mazan-Mamczarz K., Gorospe M. Antiapoptotic function of RNA-binding protein HuR effected through prothymosin &#x3b1;. EMBO J. 2005;24:1852&#x2013;1862. doi: 10.1038/sj.emboj.7600661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600661</ArticleId><ArticleId IdType="pmc">PMC1142594</ArticleId><ArticleId IdType="pubmed">15861128</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmohsen K., Kim M.M., Srikantan S., Mercken E.M., Brennan S.E., Wilson G., de Cabo R., Gorospe M. miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle. 2010;9:1354&#x2013;1359. doi: 10.4161/cc.9.7.11164.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.9.7.11164</ArticleId><ArticleId IdType="pmc">PMC3057889</ArticleId><ArticleId IdType="pubmed">20305372</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon D.A., Tolley N.D., King P.H., Nabors L.B., McIntyre T.M., Zimmerman G.A., Prescott S.M. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Investig. 2001;108:1657&#x2013;1665. doi: 10.1172/JCI12973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI12973</ArticleId><ArticleId IdType="pmc">PMC200983</ArticleId><ArticleId IdType="pubmed">11733561</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugihara M., Tsutsumi A., Suzuki E., Wakamatsu E., Suzuki T., Ogishima H., Hayashi T., Chino Y., Ishii W., Mamura M., et al. Effects of infliximab therapy on gene expression levels of tumor necrosis factor &#x3b1;, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis. Arthritis Rheum. 2007;56:2160&#x2013;2169. doi: 10.1002/art.22724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22724</ArticleId><ArticleId IdType="pubmed">17599736</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta S., Jang B.-C., Wu M.-T., Paik J.-H., Furneaux H., Hla T. The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J. Biol. Chem. 2003;278:25227&#x2013;25233. doi: 10.1074/jbc.M301813200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M301813200</ArticleId><ArticleId IdType="pubmed">12704185</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakstaite A., Maziukiene A., Silkuniene G., Kmieliute K., Gulbinas A., Dambrauskas Z. HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer. World J. Gastroenterol. 2015;21:13004&#x2013;13019. doi: 10.3748/wjg.v21.i46.13004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v21.i46.13004</ArticleId><ArticleId IdType="pmc">PMC4674719</ArticleId><ArticleId IdType="pubmed">26675757</ArticleId></ArticleIdList></Reference><Reference><Citation>Linker K., Pautz A., Fechir M., Hubrich T., Greeve J., Kleinert H. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids Res. 2005;33:4813&#x2013;4827. doi: 10.1093/nar/gki797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki797</ArticleId><ArticleId IdType="pmc">PMC1192834</ArticleId><ArticleId IdType="pubmed">16126846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajasingh J., Bord E., Luedemann C., Asai J., Hamada H., Thorne T., Qin G., Goukassian D., Zhu Y., Losordo D.W., et al. IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J. 2006;20:2112&#x2013;2114. doi: 10.1096/fj.06-6084fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.06-6084fje</ArticleId><ArticleId IdType="pubmed">16935932</ArticleId></ArticleIdList></Reference><Reference><Citation>Green L.C., Anthony S.R., Slone S., Lanzillotta L., Nieman M.L., Wu X., Robbins N., Jones S.M., Roy S., Owens A.P., et al. Human antigen R as a therapeutic target in pathological cardiac hypertrophy. JCI Insight. 2019;4 doi: 10.1172/jci.insight.121541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.121541</ArticleId><ArticleId IdType="pmc">PMC6478406</ArticleId><ArticleId IdType="pubmed">30668549</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsanou V., Milatos S., Yiakouvaki A., Sgantzis N., Kotsoni A., Alexiou M., Harokopos V., Aidinis V., Hemberger M., Kontoyiannis D.L. The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. Mol. Cell. Biol. 2009;29:2762&#x2013;2776. doi: 10.1128/MCB.01393-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01393-08</ArticleId><ArticleId IdType="pmc">PMC2682039</ArticleId><ArticleId IdType="pubmed">19307312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Modi Y., Yarovinsky T., Yu J., Collinge M., Kyriakides T., Zhu Y., Sessa W., Pardi R., Bender J.R. Macrophage &#x3b2;2 integrin&#x2013;mediated, hur-dependent stabilization of angiogenic factor&#x2013;encoding mrnas in inflammatory angiogenesis. Am. J. Pathol. 2012;180:1751&#x2013;1760. doi: 10.1016/j.ajpath.2011.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2011.12.025</ArticleId><ArticleId IdType="pmc">PMC3349897</ArticleId><ArticleId IdType="pubmed">22322302</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokoloski K.J., Dickson A.M., Chaskey E.L., Garneau N.L., Wilusz C.J., Wilusz J. Sindbis virus usurps the cellular HuR protein to stabilize its transcripts and promote productive infections in mammalian and mosquito cells. Cell Host Microbe. 2010;8:196&#x2013;207. doi: 10.1016/j.chom.2010.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.07.003</ArticleId><ArticleId IdType="pmc">PMC2929003</ArticleId><ArticleId IdType="pubmed">20709296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemay J., Maidou-Peindara P., Bader T., Ennifar E., Rain J.C., Benarous R., Liu L.X. HuR Interacts with human immu-nodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells. Retrovirology. 2008;5:47. doi: 10.1186/1742-4690-5-47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-5-47</ArticleId><ArticleId IdType="pmc">PMC2441633</ArticleId><ArticleId IdType="pubmed">18544151</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano S., Shinde A., Ito H., Kusaka H. Messenger RNA degradation may be inhibited in sporadic inclusion body myositis. Neurology. 2005;65:420&#x2013;425. doi: 10.1212/01.wnl.0000171341.76482.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000171341.76482.15</ArticleId><ArticleId IdType="pubmed">16087907</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa A., Cuadrado A., Fan J., Atasoy U., Muscat G., Mu&#xf1;oz-Canoves P., Gorospe M., Mu&#xf1;oz A. Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes. Mol. Cell. Biol. 2003;23:4991&#x2013;5004. doi: 10.1128/MCB.23.14.4991-5004.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.23.14.4991-5004.2003</ArticleId><ArticleId IdType="pmc">PMC162217</ArticleId><ArticleId IdType="pubmed">12832484</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Marco S., Mazroui R., Dallaire P., Chittur S., Tenenbaum S.A., Radzioch D., Marette A., Gallouzi I.-E. NF-&#x3ba;B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release. Mol. Cell. Biol. 2005;25:6533&#x2013;6545. doi: 10.1128/MCB.25.15.6533-6545.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.25.15.6533-6545.2005</ArticleId><ArticleId IdType="pmc">PMC1190341</ArticleId><ArticleId IdType="pubmed">16024790</ArticleId></ArticleIdList></Reference><Reference><Citation>Vainchtein I.D., Molofsky A.V. Astrocytes and Microglia: In Sickness and in Health. Trends Neurosci. 2020;43:144&#x2013;154. doi: 10.1016/j.tins.2020.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.01.003</ArticleId><ArticleId IdType="pmc">PMC7472912</ArticleId><ArticleId IdType="pubmed">32044129</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit W.J., Mrak R.E., Griffin W.S.T. Microglia and neuroinflammation: A pathological perspective. J. Neuroinflamm. 2004;1:14. doi: 10.1186/1742-2094-1-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-1-14</ArticleId><ArticleId IdType="pmc">PMC509427</ArticleId><ArticleId IdType="pubmed">15285801</ArticleId></ArticleIdList></Reference><Reference><Citation>El Khoury J., Toft M., Hickman S.E., Means T.K., Terada K., Geula C., Luster A.D. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 2007;13:432&#x2013;438. doi: 10.1038/nm1555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1555</ArticleId><ArticleId IdType="pubmed">17351623</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettenmann H., Hanisch U.-K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011;91:461&#x2013;553. doi: 10.1152/physrev.00011.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00011.2010</ArticleId><ArticleId IdType="pubmed">21527731</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogoleva V.S., Drutskaya M.S., Atretkhany K.S.-N. The role of microglia in the homeostasis of the central nervous system and neuroinflammation. Mol. Biol. 2019;53:696&#x2013;703. doi: 10.1134/S0026893319050054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0026893319050054</ArticleId><ArticleId IdType="pubmed">31661478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushal V., Schlichter L.C. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci. 2008;28:2221&#x2013;2230. doi: 10.1523/JNEUROSCI.5643-07.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5643-07.2008</ArticleId><ArticleId IdType="pmc">PMC6671848</ArticleId><ArticleId IdType="pubmed">18305255</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J.A., Das A., Ray S.K., Banik N.L. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull. 2012;87:10&#x2013;20. doi: 10.1016/j.brainresbull.2011.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2011.10.004</ArticleId><ArticleId IdType="pubmed">22024597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels T., De Schepper S., Hong S. Microglia modulate neurodegeneration in Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Science. 2020;370:66&#x2013;69. doi: 10.1126/science.abb8587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8587</ArticleId><ArticleId IdType="pubmed">33004513</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsye P., Zheng L., Si Y., Kim S., Luo W., Crossman D.K., Bratcher P.E., King P.H. HuR Promotes the Molecular Signature and Phenotype of Activated Microglia: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases. GLIA. 2017;65:945&#x2013;963. doi: 10.1002/glia.23137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23137</ArticleId><ArticleId IdType="pmc">PMC7944581</ArticleId><ArticleId IdType="pubmed">28300326</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelova D.M., Brown D.R. Microglia and the Aging Brain: Are Senescent Microglia the Key to Neurodegeneration? J. Neurochem. 2019;151:676&#x2013;688. doi: 10.1111/jnc.14860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14860</ArticleId><ArticleId IdType="pubmed">31478208</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Cu&#xe9; C., Rueda N. Cellular Senescence in Neurodegenerative Diseases. Front. Cell. Neurosci. 2020;14:16. doi: 10.3389/fncel.2020.00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00016</ArticleId><ArticleId IdType="pmc">PMC7026683</ArticleId><ArticleId IdType="pubmed">32116562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Yang X., Cristofalo V.J., Holbrook N.J., Gorospe M. Loss of HuR Is Linked to Reduced Expression of Proliferative Genes during Replicative Senescence. Mol. Cell. Biol. 2001;21:5889&#x2013;5898. doi: 10.1128/MCB.21.17.5889-5898.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.21.17.5889-5898.2001</ArticleId><ArticleId IdType="pmc">PMC87308</ArticleId><ArticleId IdType="pubmed">11486028</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo E., Farina C. Astrocytes: Key Regulators of Neuroinflammation. Trends Immunol. 2016;37:608&#x2013;620. doi: 10.1016/j.it.2016.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2016.06.006</ArticleId><ArticleId IdType="pubmed">27443914</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew M.V. Astrogliosis Perspectives. Cold Spring Harb. Perspect. Biol. 2015;7:1&#x2013;16. doi: 10.1101/cshperspect.a020420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a020420</ArticleId><ArticleId IdType="pmc">PMC4315924</ArticleId><ArticleId IdType="pubmed">25380660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon H.S., Koh S.H. Neuroinflammation in Neurodegenerative Disorders: The Roles of Microglia and Astrocytes. Transl. Neurodegener. 2020;9:42. doi: 10.1186/s40035-020-00221-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-020-00221-2</ArticleId><ArticleId IdType="pmc">PMC7689983</ArticleId><ArticleId IdType="pubmed">33239064</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao M., Xiao Z.J., Yang B., Lan Z., Fang F. Blood-brain barrier: More contributor to disruption of central nervous system homeostasis than victim in neurological disorders. Front. Neurosci. 2020;14:764. doi: 10.3389/fnins.2020.00764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00764</ArticleId><ArticleId IdType="pmc">PMC7438939</ArticleId><ArticleId IdType="pubmed">32903669</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih R.-H., Wang C.-Y., Yang C.-M. NF-kappaB signaling pathways in neurological inflammation: A mini review. Front. Mol. Neurosci. 2015;8:77. doi: 10.3389/fnmol.2015.00077.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2015.00077</ArticleId><ArticleId IdType="pmc">PMC4683208</ArticleId><ArticleId IdType="pubmed">26733801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan T., Floyd C.L., Kim S., King P.H. RNA Binding Protein Human Antigen R Is Translocated in Astrocytes Following Spinal Cord Injury and Promotes the Inflammatory Response. 2059756758J. Neurotrauma. 2017;34:1249&#x2013;1259. doi: 10.1089/neu.2016.4757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2016.4757</ArticleId><ArticleId IdType="pmc">PMC5359693</ArticleId><ArticleId IdType="pubmed">27852147</ArticleId></ArticleIdList></Reference><Reference><Citation>Skliris A., Papadaki O., Kafasla P., Karakasiliotis I., Hazapis O., Reczko M., Grammenoudi S., Bauer J., Kontoyiannis D.L. Neuroprotection requires the functions of the RNA-binding protein HuR. Cell Death Differ. 2014;22:703&#x2013;718. doi: 10.1038/cdd.2014.158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.158</ArticleId><ArticleId IdType="pmc">PMC4392069</ArticleId><ArticleId IdType="pubmed">25301069</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho M., Swash M. Amyotrophic lateral sclerosis: An update. Curr. Opin. Neurol. 2011;24:497&#x2013;503. doi: 10.1097/WCO.0b013e32834916a9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e32834916a9</ArticleId><ArticleId IdType="pubmed">21725240</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Wang S., Zheng L., Li X., Suswam E.A., Zhang X., Wheeler C.G., Nabors L., Filippova N., King P.H. Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR). Implications for Impaired Post-Transcriptional Regulation of Vascular Endothelial Growth Factor. J. Biol. Chem. 2009;284:33989&#x2013;33998. doi: 10.1074/jbc.M109.067918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.067918</ArticleId><ArticleId IdType="pmc">PMC2797169</ArticleId><ArticleId IdType="pubmed">19805546</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani P., Amadio M., Laforenza U., Dell&#x2019;Orco M., Diamanti L., Sardone V., Gagliardi S., Govoni S., Ceroni M., Pascale A., et al. Posttranscriptional regulation of SOD1 gene expression under oxidative stress: Potential role of ELAV proteins in sporadic ALS. Neurobiol. Dis. 2013;60:51&#x2013;60. doi: 10.1016/j.nbd.2013.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.08.005</ArticleId><ArticleId IdType="pubmed">23969235</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M., Lee S., Jeon Y.M., Kim S., Kwon Y., Kim H.J. The role of RDP-43 propagation in neurodegenerative diseases: Integrating insights from clinical and experimental studies. Exp. Mol. Med. 2020;52:1652&#x2013;1662. doi: 10.1038/s12276-020-00513-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-00513-7</ArticleId><ArticleId IdType="pmc">PMC8080625</ArticleId><ArticleId IdType="pubmed">33051572</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L., Zheng L., Si Y., Luo W., Dujardin G., Kwan T., Potochick N.R., Thompson S., Schneider D., King P.H. Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS: Implications for Amyotrophic Lateral Sclerosis. J. Biol. Chem. 2014;289:31792&#x2013;31804. doi: 10.1074/jbc.M114.573246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.573246</ArticleId><ArticleId IdType="pmc">PMC4231657</ArticleId><ArticleId IdType="pubmed">25239623</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J.-C., Torny F., Lacoste M., Preux P.-M., Couratier P. Hypermetabolism in ALS: Correlations with clinical and paraclinical parameters. Neurodegener. Dis. 2005;2:202&#x2013;207. doi: 10.1159/000089626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089626</ArticleId><ArticleId IdType="pubmed">16909026</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.-J., Lee L.-M., Lai H.-L., Chern Y. Aberrant activation of AMP-activated protein kinase contributes to the abnormal distribution of HuR in amyotrophic lateral sclerosis. FEBS Lett. 2015;589:432&#x2013;439. doi: 10.1016/j.febslet.2014.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.12.029</ArticleId><ArticleId IdType="pubmed">25592834</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico A., Mercuri E., Tiziano F.D., Bertini E. Spinal Muscular Atrophy. Orphanet J. Rare Dis. 2011;6:71. doi: 10.1186/1750-1172-6-71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-6-71</ArticleId><ArticleId IdType="pmc">PMC3231874</ArticleId><ArticleId IdType="pubmed">22047105</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Giessen K., Di-Marco S., Clair E., Gallouzi I.E. RNAi-Mediated HuR Depletion Leads to the Inhibition of Muscle Cell Differentiation. J. Biol. Chem. 2003;278:47119&#x2013;47128. doi: 10.1074/jbc.M308889200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M308889200</ArticleId><ArticleId IdType="pubmed">12944397</ArticleId></ArticleIdList></Reference><Reference><Citation>Joassard O.R., B&#xe9;langer G., Karmouch J., Lunde J.A., Shukla A.H., Chopard A., Legay C., Jasmin B.J. HuR Mediates Changes in the Stability of AChR &#x3b2;-Subunit MRNAs after Skeletal Muscle Denervation. J. Neurosci. 2015;35:10949&#x2013;10962. doi: 10.1523/JNEUROSCI.1043-15.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1043-15.2015</ArticleId><ArticleId IdType="pmc">PMC6605275</ArticleId><ArticleId IdType="pubmed">26245959</ArticleId></ArticleIdList></Reference><Reference><Citation>Talwar S., Jin J., Carroll B., Liu A., Gillespie M.B., Palanisamy V. Caspase-Mediated Cleavage of RNA-Binding Protein HuR Regulates c-Myc Protein Expression after Hypoxic Stress. J. Biol. Chem. 2011;286:32333&#x2013;32343. doi: 10.1074/jbc.M111.255927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.255927</ArticleId><ArticleId IdType="pmc">PMC3173192</ArticleId><ArticleId IdType="pubmed">21795698</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Roretz C., Gallouzi I.E. Protein Kinase RNA/FADD/Caspase-8 Pathway Mediates the Proapoptotic Activity of the RNA-Binding Protein Human Antigen R (HuR) J. Biol. Chem. 2010;285:16806&#x2013;16813. doi: 10.1074/jbc.M109.087320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.087320</ArticleId><ArticleId IdType="pmc">PMC2878037</ArticleId><ArticleId IdType="pubmed">20353946</ArticleId></ArticleIdList></Reference><Reference><Citation>Alisi A., Spaziani A., Anticoli S., Ghidinelli M., Balsano C. PKR Is a Novel Functional Direct Player That Coordinates Skeletal Muscle Differentiation via P38MAPK/AKT Pathways. Cell. Signal. 2008;20:534&#x2013;542. doi: 10.1016/j.cellsig.2007.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2007.11.006</ArticleId><ArticleId IdType="pubmed">18164587</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooq F., Balabanian S., Liu X., Holcik M., MacKenzie A. P38 Mitogen-Activated Protein Kinase Stabilizes SMN MRNA through RNA Binding Protein HuR. Hum. Mol. Genet. 2009;18:4035&#x2013;4045. doi: 10.1093/hmg/ddp352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp352</ArticleId><ArticleId IdType="pubmed">19648294</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooq F., Abad&#xed;a-Molina F., MacKenzie D., Hadwen J., Shamim F., O&#x2019;Reilly S., Holcik M., MacKenzie A. Celecoxib Increases SMN and Survival in a Severe Spinal Muscular Atrophy Mouse Model via P38 Pathway Activation. Hum. Mol. Genet. 2013;22:3415&#x2013;3424. doi: 10.1093/hmg/ddt191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt191</ArticleId><ArticleId IdType="pubmed">23656793</ArticleId></ArticleIdList></Reference><Reference><Citation>Matute-Blanch C., Montalban X., Comabella M. Handbook of Clinical Neurology. Volume 8. Elsevier; Amsterdam, The Netherlands: 2018. Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system; pp. 67&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-12-804279-3.00005-8</ArticleId><ArticleId IdType="pubmed">29110780</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Loughlin E., Madore C., Lassmann H., Butovsky O. microglial phenotypes and functions in multiple sclerosis. Cold Spring Harb. Perspect. Med. 2018;8:a028993. doi: 10.1101/cshperspect.a028993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028993</ArticleId><ArticleId IdType="pmc">PMC5793738</ArticleId><ArticleId IdType="pubmed">29419406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna M.D., Quattrone A., Galeotti N. Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis. Neuropharmacology. 2017;123:116&#x2013;125. doi: 10.1016/j.neuropharm.2017.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2017.06.005</ArticleId><ArticleId IdType="pubmed">28599923</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco I., Ugolini F., Lana D., Coppi E., Dettori I., Gaviano L., Nosi D., Pedata F., Giovannini M.G., Pugliese A.M. The selective antagonism of adenosine A2B receptors reduces the synaptic failure and neuronal death induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro. Front. Pharmacol. 2018;24:399. doi: 10.3389/fphar.2018.00399.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00399</ArticleId><ArticleId IdType="pmc">PMC5928446</ArticleId><ArticleId IdType="pubmed">29740323</ArticleId></ArticleIdList></Reference><Reference><Citation>Maraula G., Traini C., Mello T., Coppi E., Galli A., Pedata F., Pugliese A.M. Effects of oxygen and glucose deprivation on synaptic transmission in rat dentate gyrus: Role of A(2A) adenosine receptors. Neuropharmacology. 2013;67:511&#x2013;520. doi: 10.1016/j.neuropharm.2012.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2012.12.002</ArticleId><ArticleId IdType="pubmed">23261865</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppi E., Pedata F., Gibb A.J. P2Y1 receptor modulation of Ca2+-activated K+ currents in medium spiny neurons from neonatal rat striatal slices. J. Neurophysiol. 2012;107:1009&#x2013;1021. doi: 10.1152/jn.00816.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00816.2009</ArticleId><ArticleId IdType="pmc">PMC3289470</ArticleId><ArticleId IdType="pubmed">22131374</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwak Y.S., Hulsebosch C.E., Leem J.W. neuronal-glial interactions maintain chronic neuropathic pain after spinal cord injury. Neural Plast. 2017;2017:1&#x2013;14. doi: 10.1155/2017/2480689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/2480689</ArticleId><ArticleId IdType="pmc">PMC5603132</ArticleId><ArticleId IdType="pubmed">28951789</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna M.D., Ghelardini C., Galeotti N. HuD-mediated distinct BDNF regulatory pathways promote regeneration after nerve injury. Brain Res. 2017;1659:55&#x2013;63. doi: 10.1016/j.brainres.2017.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2017.01.019</ArticleId><ArticleId IdType="pubmed">28111162</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgonetti V., Sanna M.D., Lucarini L., Galeotti N. Targeting the RNA-binding protein HuR alleviates neuroinflammation in experimental autoimmune encephalomyelitis: Potential therapy for multiple sclerosis. Neurother. J. Am. Soc. Exp. Neuro-Ther. 2020;18:412&#x2013;429. doi: 10.1007/s13311-020-00958-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-020-00958-8</ArticleId><ArticleId IdType="pmc">PMC8116432</ArticleId><ArticleId IdType="pubmed">33200288</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgonetti V., Galeotti N. Intranasal delivery of an antisense oligonucleotide to the RNA-binding protein HuR relieves nerve injury-induced neuropathic pain. Pain. 2020;162:1500&#x2013;1510. doi: 10.1097/j.pain.0000000000002154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002154</ArticleId><ArticleId IdType="pubmed">33259457</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser T., Akg&#xfc;n K., Proschmann U., Sellner J., Ziemssen T. The role of TH17 cells in multiple sclerosis: Therapeutic implications. Autoimmun. Rev. 2020;19:102647. doi: 10.1016/j.autrev.2020.102647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102647</ArticleId><ArticleId IdType="pubmed">32801039</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Cascio J., Magee J.D., Techasintana P., Gubin M.M., Dahm G.M., Calaluce R., Yu S., Atasoy U. Posttranscriptional gene regulation of IL-17 by the RNA-binding protein HuR is required for initiation of experimental autoimmune encephalomyelitis. J. Immunol. 2013;191:5441&#x2013;5450. doi: 10.4049/jimmunol.1301188.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301188</ArticleId><ArticleId IdType="pmc">PMC3831112</ArticleId><ArticleId IdType="pubmed">24166976</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Martindale J.L., Cramer C., Gorospe M., Atasoy U., Drew P.D., Yu S. The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells. J. Biol. Chem. 2017;292:14532&#x2013;14543. doi: 10.1074/jbc.M117.782771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.782771</ArticleId><ArticleId IdType="pmc">PMC5582845</ArticleId><ArticleId IdType="pubmed">28684423</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Martindale J.L., Abdelmohsen K., Kumar G., Fortina P.M., Gorospe M., Rostami A., Yu S. RNA-binding protein HuR promotes TH17 cell differentiation and can be targeted to reduce autoimmune neuroinflammation. J. Immunol. 2020;204:2076&#x2013;2087. doi: 10.4049/jimmunol.1900769.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900769</ArticleId><ArticleId IdType="pmc">PMC7534900</ArticleId><ArticleId IdType="pubmed">32169842</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistono C., Monti M.C., Marchesi N., Boiocchi C., Campagnoli L.I.M., Morlotti D., Cuccia M., Govoni S., Montomoli C., Mallucci G., et al. Unraveling a New Player in Multiple Sclerosis Pathogenesis: The RNA-Binding Protein HuR. Mult. Scler. Relat. Disord. 2020;41:102048. doi: 10.1016/j.msard.2020.102048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2020.102048</ArticleId><ArticleId IdType="pubmed">32200342</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheckel C., Drapeau E., Frias M.A., Park C.Y., Fak J., Zucker-Scharff I., Kou Y., Haroutunian V., Ma&#x2019;Ayan A., Buxbaum J.D., et al. Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain. eLife. 2016;5:e10421. doi: 10.7554/eLife.10421.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.10421</ArticleId><ArticleId IdType="pmc">PMC4798961</ArticleId><ArticleId IdType="pubmed">26894958</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna M., Quattrone A., Ghelardini C., Galeotti N. PKC-mediated HuD&#x2013;GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy. Pharmacol. Res. 2014;81:44&#x2013;53. doi: 10.1016/j.phrs.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2014.02.004</ArticleId><ArticleId IdType="pubmed">24565699</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna M.D., Quattrone A., Galeotti N. Antidepressant-like actions by silencing of neuronal ELAV-like RNA-binding proteins HuB and HuC in a model of depression in male mice. Neuropharmacology. 2018;135:444&#x2013;454. doi: 10.1016/j.neuropharm.2018.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2018.04.001</ArticleId><ArticleId IdType="pubmed">29626565</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansfield K.D., Keene J.D. Neuron-specific ELAV/Hu proteins suppress HuR mRNA during neuronal differentiation by alternative polyadenylation. Nucleic Acids Res. 2011;40:2734&#x2013;2746. doi: 10.1093/nar/gkr1114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr1114</ArticleId><ArticleId IdType="pmc">PMC3315332</ArticleId><ArticleId IdType="pubmed">22139917</ArticleId></ArticleIdList></Reference><Reference><Citation>Akamatsu W., Okano H.J., Osumi N., Inoue T., Nakamura S., Sakakibara S., Miura M., Matsuo N., Darnell R.B., Okano H. Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the Central and the Peripheral Nervous Systems. Proc. Natl. Acad. Sci. USA. 1999;96:9885&#x2013;9890. doi: 10.1073/pnas.96.17.9885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.17.9885</ArticleId><ArticleId IdType="pmc">PMC22305</ArticleId><ArticleId IdType="pubmed">10449789</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammatikakis I., Abdelmohsen K., Gorospe M. Posttranslational control of HuR function. Wiley Interdiscip. Rev. RNA. 2016;8:e1372. doi: 10.1002/wrna.1372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1372</ArticleId><ArticleId IdType="pmc">PMC5607777</ArticleId><ArticleId IdType="pubmed">27307117</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>